Topic 05 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 03 - 15 Topics

cite ad title authors publish year publish time dataset abstract mentions covid pmcid pubmed id doi cord uid topic weight Similarity scispacy Similarity specter
1 Crisci_2012 Virus-like particles: The new frontier of vaccines for animal viral infections Crisci, Elisa; Bárcena, Juan; Montoya, María 2012 2012-08-15 PMC N PMC7112581 22705417.0 10.1016/j.vetimm.2012.04.026 e8l9w41u 0.799676 Conzelmann_1996 Crisci_2013
2 Crisci_2013 Virus-like particle-based vaccines for animal viral infections Crisci, Elisa; Bárcena, Juan; Montoya, María 2013 2013-09-30 PMC N PMC7115488 10.1016/j.inmuno.2012.08.002 jjluocxz 0.781825 Conzelmann_1996 Crisci_2012
3 Morrison_2010 Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens Morrison, Trudy G 2010 2010-09-01 PMC N PMC3039435 21339837.0 10.2217/fvl.10.50 4fehbpjr 0.716336
4 Donaldson_2018 Virus-like particle vaccines: immunology and formulation for clinical translation Donaldson, Braeden; Lateef, Zabeen; Walker, Greg F.; Young, Sarah L.; Ward, Vernon K. 2018 2018-09-19 PMC N PMC7103734 30173619.0 10.1080/14760584.2018.1516552 n2ncamqh 0.714415 Forde_2005
5 Jazayeri_2019 Recent advances in delivery of veterinary DNA vaccines against avian pathogens Jazayeri, Seyed Davoud; Poh, Chit Laa 2019 2019-10-10 COMM-USE N PMC6785882 31601266.0 10.1186/s13567-019-0698-z fmda6klr 0.691641 Forde_2005
6 Li_L_2012 The future of human DNA vaccines Li, Lei; Saade, Fadi; Petrovsky, Nikolai 2012 2012-12-01 PMC N PMC3511659 22981627.0 10.1016/j.jbiotec.2012.08.012 qpgq6dgn 0.684179 Forde_2005, Conzelmann_1996, Li_L_2015 Li_L_2015, Liu_L_2017, Saade_2012
7 McCullough_2009 Targeting the porcine immune system—Particulate vaccines in the 21st century McCullough, Kenneth C.; Summerfield, Artur 2009 2009-03-31 PMC N PMC7103233 18771683.0 10.1016/j.dci.2008.07.015 w8kfwd7v 0.679948 Conzelmann_1996
8 Liu_M_2019 A Comparison of Plasmid DNA and mRNA as Vaccine Technologies Liu, Margaret A. 2019 2019-04-24 COMM-USE N PMC6631684 31022829.0 10.3390/vaccines7020037 0fx1b7ph 0.668556 Forde_2005, Li_L_2015, Conzelmann_1996 Li_L_2015, Liu_L_2017
9 Liu_L_2017 Clinical Use of DNA Vaccines Liu, Li; Morrow, Matthew P.; Bagarazzi, Mark 2017 2017-07-25 PMC N PMC7153459 10.1007/978-3-319-32886-7_106 qautse9a 0.652771 Forde_2005, Conzelmann_1996, Li_L_2015 Li_L_2015
10 Raeven_2018 Systems vaccinology and big data in the vaccine development chain Raeven, René H. M.; van Riet, Elly; Meiring, Hugo D.; Metz, Bernard; Kersten, Gideon F. A. 2018 2018-11-13 NONCOMM N PMC6283655 30317555.0 10.1111/imm.13012 3ywtkd3k 0.651778 Johnson_2018, UNKNOWN_2020, Kanekiyo_2019 Wack_2005, Poland_2018
11 Stobart_2017 Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine Stobart, Christopher C.; Nosek, Jenna M.; Moore, Martin L. 2017 2017-12-05 COMM-USE N PMC5723287 29259600.0 10.3389/fmicb.2017.02412 dvw4ajtv 0.651044
12 Plitnick_2013 Chapter 9 Global Regulatory Guidelines for Vaccines Plitnick, Lisa M. 2013 2013-12-31 PMC N PMC7149671 10.1016/b978-0-12-394810-6.00009-5 3c68yz4j 0.639858 Forde_2005 Moingeon_2002, Loessner_2012
13 Bull_2015 Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it? Bull, J. J. 2015 2015-07-31 COMM-USE N PMC4811365 27034780.0 10.1093/ve/vev005 3xb3ibsq 0.638068 UNKNOWN_2004, Conzelmann_1996
14 Moingeon_2002 Delivery technologies for human vaccines Moingeon, Philippe; de Taisne, Charles; Almond, Jeffrey 2002 2002-07-23 PMC N PMC7110014 12176848.0 10.1093/bmb/62.1.29 v5wxkdbk 0.623763 Bramwell_2005, Pashine_2006
15 Li_L_2015 Molecular mechanisms for enhanced DNA vaccine immunogenicity Li, Lei; Petrovsky, Nikolai 2015 2015-12-28 PMC N PMC4955855 26707950.0 10.1586/14760584.2016.1124762 f30dw3cn 0.622615 Forde_2005, Conzelmann_1996 Liu_L_2017, Saade_2012
16 Nandy_2019 Bioinformatics in Design of Antiviral Vaccines Nandy, Ashesh; Basak, Subhash C. 2019 2019-12-31 PMC N PMC7149942 10.1016/b978-0-12-801238-3.10878-5 d3bs7yzc 0.610296 UNKNOWN_2004 Dangi_2018, Nandy_2016
17 Francis_2018 Recent Advances in Vaccine Technologies Francis, Michael James 2018 2018-03-31 PMC N PMC7132473 29217317.0 10.1016/j.cvsm.2017.10.002 4xkux5z4 0.602929 Walker_2010, Forde_2005 Brun_2008
18 Matsuo_2013 Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine delivery Matsuo, Kazuhiko; Hirobe, Sachiko; Okada, Naoki; Nakagawa, Shinsaku 2013 2013-05-01 PMC N PMC7125630 23523401.0 10.1016/j.vaccine.2013.03.022 gcuz6edd 0.599251 Liu_Y_2014, UNKNOWN_2004, Johnson_2018, Conzelmann_1996, van_Kampen_2015
19 Suschak_2017 Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity Suschak, John J.; Williams, James A.; Schmaljohn, Connie S. 2017 2017-06-12 NONCOMM N PMC5718814 28604157.0 10.1080/21645515.2017.1330236 b0izt9hq 0.595007 Forde_2005, Conzelmann_1996, Li_L_2015 Liu_L_2017, Li_L_2015
20 Hong_2013 Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine Hong, Xiaoyun; Wei, Liangming; Wu, Fei; Wu, Zaozhan; Chen, Lizhu; Liu, Zhenguo; Yuan, Weien 2013 2013-09-04 NONCOMM N PMC3771849 24039404.0 10.2147/dddt.s44401 pjv3wy80 0.594809 Liu_Y_2014, Giannitelli_2018, Kumar_2019 Patravale_2012
21 Loessner_2012 Employing Live Microbes for Vaccine Delivery Loessner, Holger; Schwantes, Astrid; Hamdorf, Matthias; Komor, Uliana; Leschner, Sara; Weiss, Siegfried 2012 2012-02-18 PMC N PMC7123214 10.1007/978-3-7091-0709-6_5 9a4jw0ze 0.574647 Forde_2005, Conzelmann_1996
22 Charlton_Hume_2017 Platform technologies for modern vaccine manufacturing Charlton Hume, Hayley K.; Lua, Linda H.L. 2017 2017-08-16 PMC N PMC7115529 28347504.0 10.1016/j.vaccine.2017.02.069 47sgz7l3 0.573706 Kanekiyo_2019, May_E_2016 Brun_2008
23 Rodrigues_2015 Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology Rodrigues, Ana F.; Soares, Hugo R.; Guerreiro, Miguel R.; Alves, Paula M.; Coroadinha, Ana S. 2015 2015-07-24 PMC N PMC7161866 26212697.0 10.1002/biot.201400387 q3bc5x63 0.568055 Forde_2005
24 Meloen_1995 Basic aspects of immunomodulation through active immunization Meloen, R.H. 1995 1995-06-30 PMC N 10.1016/0301-6226(95)00014-c 0jqhu890 0.565390 Masihi_2005
25 Ramezanpour_2016 Vector-based genetically modified vaccines: Exploiting Jenner’s legacy Ramezanpour, Bahar; Haan, Ingrid; Osterhaus, Ab; Claassen, Eric 2016 2016-12-07 PMC N PMC7115478 28029542.0 10.1016/j.vaccine.2016.06.059 cp32wy70 0.533369 Forde_2005
26 Martinez-Gil_2018 Chapter One The Role of Self-Assembling Lipid Molecules in Vaccination Martinez-Gil, Luis; Goff, Peter H.; Tan, Gene S. 2018 2018-12-31 PMC N PMC7147077 10.1016/bs.abl.2017.12.001 kbihjy2b 0.529652 Forde_2005, Conzelmann_1996
27 Saade_2012 Technologies for enhanced efficacy of DNA vaccines Saade, Fadi; Petrovsky, Nikolai 2012 2012-02-01 PMC N PMC3293989 22309668.0 10.1586/erv.11.188 nh1eqwmo 0.528376 Forde_2005, Conzelmann_1996 Li_L_2015, Liu_L_2017, Li_L_2012
28 Sarkar_2019 Selection of adjuvants for vaccines targeting specific pathogens Sarkar, Indranil; Garg, Ravendra; van Drunen Littel-van den Hurk, Sylvia 2019 2019-04-22 PMC N PMC7103699 31009255.0 10.1080/14760584.2019.1604231 ywb26cq6 0.528026 Pashine_2006
29 Nandy_2016 A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide Vaccines Nandy, Ashesh; Basak, Subhash C. 2016 2016-05-04 COMM-USE N PMC4881492 27153063.0 10.3390/ijms17050666 yqciq9m5 0.526126 Johnson_2018, Kanekiyo_2019, Conzelmann_1996 Dangi_2018
30 Babiuk_1994 Veterinary vaccines Babiuk, L.A.; Potter, A.A. 1994 1994-12-31 PMC N 10.1016/0734-9750(94)90021-3 hpm1x0bi 0.526011 Conzelmann_1996, Forde_2005
31 Huang_2010 Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) Huang, Y.W.; Meng, X.J. 2010 2010-12-31 PMC N PMC7132426 20655962.0 10.1016/j.virusres.2010.07.020 pp8rmkep 0.525618 Walker_2010
32 Tatsis_2004 Adenoviruses as vaccine vectors Tatsis, Nia; Ertl, Hildegund C.J. 2004 2004-10-31 PMC N PMC7106330 15451446.0 10.1016/j.ymthe.2004.07.013 aw8p35c5 0.525130 Conzelmann_1996, Forde_2005
33 Pashine_2006 4 Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants Pashine, Achal; Ulmer, Jeffrey B.; Valiante, Nicholas M. 2006 2006-12-31 PMC N 10.1016/b978-012088403-2/50005-8 0whyoiqj 0.506064
34 Charlton_Hume_2018 Synthetic biology for bioengineering virus‐like particle vaccines Charlton Hume, Hayley K.; Vidigal, João; Carrondo, Manuel J. T.; Middelberg, Anton P. J.; Roldão, António; Lua, Linda H. L. 2018 2018-12-31 PMC N PMC7161758 30597533.0 10.1002/bit.26890 3a9vjpvn 0.500774 Conzelmann_1996, Forde_2005
35 Hammond_2009 Plant Production of Veterinary Vaccines and Therapeutics Hammond, R. W.; Nemchinov, L. G. 2009 2009-01-01 PMC N PMC7122226 19401822.0 10.1007/978-3-540-70868-1_5 xasktk5c 0.494718 Sahai_2013, Munshi_2018
36 Flower_2010 Computer aided selection of candidate vaccine antigens Flower, Darren R; Macdonald, Isabel K; Ramakrishnan, Kamna; Davies, Matthew N; Doytchinova, Irini A 2010 2010-11-03 COMM-USE N PMC2981880 21067543.0 10.1186/1745-7580-6-s2-s1 3xk2w0d2 0.493548 Johnson_2018, UNKNOWN_2004, Castrignano_2015 Dangi_2018
37 Syomin_2019 Virus-Like Particles as an Instrument of Vaccine Production Syomin, B. V.; Ilyin, Y. V. 2019 2019-06-17 PMC N PMC7088979 10.1134/s0026893319030154 7mu530yp 0.489943 Conzelmann_1996 Rosales-Mendoza_2019
38 Poland_2018 Personalized vaccinology: A review Poland, G.A.; Ovsyannikova, I.G.; Kennedy, R.B. 2018 2018-08-28 PMC N PMC5792371 28774561.0 10.1016/j.vaccine.2017.07.062 ipa017wz 0.488115 UNKNOWN_2004
39 Dodson_2011 Potential targets for pancreatic cancer immunotherapeutics Dodson, Lindzy F; Hawkins, William G; Goedegebuure, Peter 2011 2011-04-01 PMC N PMC3148788 21463193.0 10.2217/imt.11.10 u085k1hi 0.482713
40 Wack_2005 Vaccinology at the beginning of the 21st century Wack, Andreas; Rappuoli, Rino 2005 2005-08-31 PMC N PMC7125631 15950445.0 10.1016/j.coi.2005.05.005 qfdxri93 0.478301 Conzelmann_1996, UNKNOWN_2004, Alcami_2000
41 Osterrieder_2018 Attenuation of Viruses by Large-Scale Recoding of their Genomes: the Selection Is Always Biased Osterrieder, Nikolaus; Kunec, Dusan 2018 2018-01-19 PMC N PMC7100164 10.1007/s40588-018-0080-3 vgnvpz6y 0.471484 Conzelmann_1996, Johnson_2018
42 O’Connell_2020 Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises O’Connell, Aoife K.; Douam, Florian 2020 2020-01-21 COMM-USE N PMC7157703 31973073.0 10.3390/vaccines8010036 7br852ma 0.467774 Forde_2005, Alcami_2000
43 Brun_2008 Antigen delivery systems for veterinary vaccine development Viral-vector based delivery systems Brun, Alejandro; Albina, Emmanuel; Barret, Tom; Chapman, David A.G.; Czub, Markus; Dixon, Linda K.; Keil, Günther M.; Klonjkowski, Bernard; Le Potier, Marie-Frédérique; Libeau, Geneviève; Ortego, Javier; Richardson, Jennifer; Takamatsu, Haru-H. 2008 2008-12-02 PMC N PMC7131726 18838097.0 10.1016/j.vaccine.2008.09.044 vc9ytkio 0.449717 Conzelmann_1996, Johnson_2018, Alcami_2000
44 Plotkin_2005 Vaccines: past, present and future Plotkin, Stanley A 2005 2005-04-05 PMC N PMC7095920 15812490.0 10.1038/nm1209 k5u9nt8b 0.448599 Forde_2005, Conzelmann_1996
45 Rybicki_2010 Plant‐made vaccines for humans and animals Rybicki, Edward P. 2010 2010-03-11 PMC N PMC7167690 20233333.0 10.1111/j.1467-7652.2010.00507.x xg3gfpb9 0.445896 Conzelmann_1996
46 Rosales-Mendoza_2019 Virus-Like Particles-Based Mucosal Nanovaccines Rosales-Mendoza, Sergio; González-Ortega, Omar 2019 2019-11-08 PMC N PMC7120988 10.1007/978-3-030-31668-6_10 bfi48hcn 0.441561
47 Rynda-Apple_2014 Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung Rynda-Apple, Agnieszka; Patterson, Dustin P; Douglas, Trevor 2014 2014-08-01 PMC N PMC4415509 25325241.0 10.2217/nnm.14.107 j5hisbfu 0.436662
48 He_Y_2012 Omics‐Based Systems Vaccinology for Vaccine Target Identification He, Yongqun 2012 2012-10-18 PMC N PMC7163697 10.1002/ddr.21049 5m7q92fu 0.433542 Vernikos_2008, Weinrich_2009
49 Chen_2011 Advances of bioinformatics tools applied in virus epitopes prediction Chen, Ping; Rayner, Simon; Hu, Kang-hong 2011 2011-02-18 PMC N PMC7090880 21331885.0 10.1007/s12250-011-3159-4 zmoayelz 0.431647 Johnson_2018, UNKNOWN_2004
50 Moss_2009 Prospects for control of emerging infectious diseases with plasmid DNA vaccines Moss, Ronald B 2009 2009-09-07 COMM-USE N PMC2746192 19735569.0 10.1186/1476-8518-7-3 1a5u7uux 0.429888 Forde_2005, Conzelmann_1996 Lu_S_2009
51 Stern_2019 The development of inovirus-associated vector vaccines using phage-display technologies Stern, Zachariah; Stylianou, Dora C.; Kostrikis, Leondios G. 2019 2019-09-08 PMC N PMC7103683 31373843.0 10.1080/14760584.2019.1651649 oxjd263z 0.426333 Conzelmann_1996
52 Lu_S_2009 Chapter 8 DNA Vaccines for Biodefense and Emerging and Neglected Infectious Diseases Lu, Shan; Grimes-Serrano, Jill M.; Wang, Shixia 2009 2009-12-31 PMC N PMC7150048 10.1016/b978-0-12-369408-9.00008-1 x3at6mgp 0.425677 Forde_2005
53 Kanekiyo_2017 Chapter 4 Virus-Like Particle and Nanoparticle Vaccines Kanekiyo, M.; Buck, C.B. 2017 2017-12-31 PMC N PMC7150090 10.1016/b978-0-12-802302-0.00003-0 zlr7lkqx 0.425310 Conzelmann_1996, Kanekiyo_2019, Johnson_2018
54 Greenberg_2016 Vaccination against Viruses Greenberg, Harry B.; Dormitzer, Philip R. 2016 2016-12-31 PMC N PMC7152391 10.1016/b978-0-12-374279-7.14016-0 dqikrmk7 0.425310
55 Cui_Z_2005 DNA Vaccine Cui, Zhengrong 2005 2005-12-31 PMC N PMC7119308 16096015.0 10.1016/s0065-2660(05)54011-2 cetmg1km 0.422741 Conzelmann_1996, Bradbury_2003, Sabroe_2007 Li_L_2015, Liu_L_2017
56 Ward_2020 Innovations in structure-based antigen design and immune monitoring for next generation vaccines Ward, Andrew B; Wilson, Ian A 2020 2020-04-22 PMC N 10.1016/j.coi.2020.03.013 7y8rj9h5 0.422403 Johnson_2018, Conzelmann_1996, Bramwell_2005
57 Kutzler_2008 DNA vaccines: ready for prime time? Kutzler, Michele A.; Weiner, David B. 2008 2008-10-01 PMC N PMC4317294 18781156.0 10.1038/nrg2432 rb1r88oq 0.411921 Conzelmann_1996, Bradbury_2003 Li_L_2015, Liu_L_2017
58 Gerdts_2017 Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses Gerdts, Volker; Zakhartchouk, Alexander 2017 2017-07-31 PMC N PMC7117160 27964998.0 10.1016/j.vetmic.2016.11.029 jb7u9xn6 0.409759 Walker_2010
59 Chappuis_1995 Control of canine distemper Chappuis, G. 1995 1995-05-31 PMC N 8588329.0 10.1016/0378-1135(95)00028-9 scwy859p 0.408835 Forde_2005, Morrison_2010
60 Jiskoot_2019 Vaccines Jiskoot, Wim; Kersten, Gideon F. A.; Mastrobattista, Enrico; Slütter, Bram 2019 2019-04-14 PMC N PMC7123827 10.1007/978-3-030-00710-2_14 xjtz13ol 0.407634 Forde_2005
61 Premanand_2018 Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development Premanand, Balraj; Zhong Wee, Poh; Prabakaran, Mookkan 2018 2018-05-31 COMM-USE N PMC6024371 29857561.0 10.3390/v10060298 45tre8rn 0.406546 Conzelmann_1996, Forde_2005
62 Dumonteil_2007 DNA Vaccines against Protozoan Parasites: Advances and Challenges Dumonteil, Eric 2007 2007-06-24 PMC N PMC1940056 17710244.0 10.1155/2007/90520 1n69h3i3 0.401941 Conzelmann_1996
63 Dangi_2018 Advanced In Silico Tools for Designing of Antigenic Epitope as Potential Vaccine Candidates Against Coronavirus Dangi, Mehak; Kumari, Rinku; Singh, Bharat; Chhillar, Anil Kumar 2018 2018-10-14 PMC N PMC7120312 10.1007/978-981-13-1562-6_15 i7z0tdrk 0.395207 Conzelmann_1996, Bradbury_2003
64 Heldens_2008 Veterinary vaccine development from an industrial perspective Heldens, J.G.M.; Patel, J.R.; Chanter, N.; ten Thij, G.J.; Gravendijck, M.; Schijns, V.E.J.C.; Langen, A.; Schetters, Th.P.M. 2008 2008-10-31 PMC N PMC7110856 18313956.0 10.1016/j.tvjl.2007.11.009 4ynsgu6c 0.389563 Loessner_2012
65 Bambini_2009 The use of genomics in microbial vaccine development Bambini, Stefania; Rappuoli, Rino 2009 2009-03-31 PMC N PMC7108364 19150507.0 10.1016/j.drudis.2008.12.007 43pomco2 0.388155 Conzelmann_1996, Djikeng_2009
66 Schnierle_2007 Recombinant poxvirus vaccines in biomedical research Schnierle, Barbara S.; Suezer, Yasemin; Sutter, Gerd 2007 2007-01-01 PMC N PMC7123444 10.1007/978-3-7643-7557-7_15 mmh6503o 0.384302 Conzelmann_1996
67 Boudet_2010 Vaccines for the Elderly: The Quest for the Ideal Animal Model Boudet, F. 2010 2010-01-31 PMC N PMC7094446 19897204.0 10.1016/j.jcpa.2009.10.005 dkqxfqk6 0.382485 Kiros_2012, Johnson_2018 Poland_2018
68 Folgori_2012 Engineered Viruses as Vaccine Platforms Folgori, Antonella; Capone, Stefania 2012 2012-03-29 PMC N PMC7120934 10.1007/978-94-007-4543-8_4 xvji54bo 0.380054 Forde_2005, Conzelmann_1996 Tatsis_2004
69 Chong_2019 Vaccine Target Discovery Chong, Li C.; Khan, Asif M. 2019 2019-12-31 PMC N PMC7148608 10.1016/b978-0-12-809633-8.20100-3 qgwmlcfr 0.378231 UNKNOWN_2004, Tan_S_2007, Johnson_2018 Murtaugh_2014
70 McVey_2010 Vaccines in Veterinary Medicine: A Brief Review of History and Technology McVey, Scott; Shi, Jishu 2010 2010-05-31 PMC N PMC7124274 20471523.0 10.1016/j.cvsm.2010.02.001 8mw2kpmr 0.377209 Murtaugh_2014
71 O'Hagan_2003 Recent advances in the discovery and delivery of vaccine adjuvants O'Hagan, Derek T.; Valiante, Nicholas M. 2003 2003-01-01 PMC N PMC7097252 12951579.0 10.1038/nrd1176 p0np6fvn 0.367027 Johnson_2018, Tan_S_2007, UNKNOWN_2004, Bramwell_2005
72 Cassone_2007 Fungal Vaccines and Vaccination: Problems and Perspectives Cassone, Antonio MD 2007 2007-01-01 PMC N PMC7121605 10.1007/1-4020-5492-0_21 0uumih5h 0.364750
73 Lee_J_2018 Engineering DNA vaccines against infectious diseases Lee, Jihui; Arun Kumar, Shreedevi; Jhan, Yong Yu; Bishop, Corey J. 2018 2018-10-15 PMC N PMC7105045 30172933.0 10.1016/j.actbio.2018.08.033 pux58dut 0.363785 Forde_2005, Johnson_2018, Conzelmann_1996 Liu_L_2017
74 Mooney_2013 A systems framework for vaccine design Mooney, Michael; McWeeney, Shannon; Canderan, Glenda; Sékaly, Rafick-Pierre 2013 2013-10-31 PMC N PMC7127551 24358511.0 10.1016/j.coi.2013.09.014 o4r34pff 0.362444 UNKNOWN_2004, Tan_S_2007, Johnson_2018 Mooney_2013, Bramwell_2005
75 Salyaev_2017 Chapter 10 Plant-Based Peroral Vaccines Salyaev, Rurik K.; Rekoslavskaya, Natalya I. 2017 2017-12-31 PMC N PMC7152130 10.1016/b978-0-323-52725-5.00010-1 7odykzds 0.360793 Forde_2005 Sahai_2013, Munshi_2018
76 Chattopadhyay_2017 Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation Chattopadhyay, Saborni; Chen, Jui-Yi; Chen, Hui-Wen; Hu, Che-Ming Jack 2017 2017-06-09 NONCOMM N PMC5646730 29071191.0 10.7150/ntno.19796 7q2wkwrf 0.358916 Conzelmann_1996, Liu_Y_2014, Tan_S_2007
77 Renukaradhya_2015 Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation Renukaradhya, Gourapura J.; Narasimhan, Balaji; Mallapragada, Surya K. 2015 2015-12-10 None N PMC4760633 26410807.0 10.1016/j.jconrel.2015.09.047 w813iar2 0.356998 Forde_2005, Conzelmann_1996
78 Kanekiyo_2019 New Vaccine Design and Delivery Technologies Kanekiyo, Masaru; Ellis, Daniel; King, Neil P 2019 2019-04-15 PMC N PMC6452296 30715361.0 10.1093/infdis/jiy745 nlnugpty 0.352990 Johnson_2018, UNKNOWN_2004 Brun_2008
79 Castelli_2013 Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides Castelli, Matteo; Cappelletti, Francesca; Diotti, Roberta Antonia; Sautto, Giuseppe; Criscuolo, Elena; Dal Peraro, Matteo; Clementi, Nicola 2013 2013-06-26 COMM-USE N PMC3710646 23878584.0 10.1155/2013/521231 jpo9oomb 0.350167
80 Mason_2011 Plant-Derived Antigens as Mucosal Vaccines Mason, H. S.; Herbst-Kralovetz, M. M. 2011 2011-08-03 PMC N PMC7122597 21811930.0 10.1007/82_2011_158 zkuj22oc 0.347082 Conzelmann_1996, Forde_2005
81 Bramwell_2005 The rational design of vaccines Bramwell, Vincent W.; Perrie, Yvonne 2005 2005-11-15 PMC N PMC7108399 16257375.0 10.1016/s1359-6446(05)03600-7 swwz4kzd 0.343644 Johnson_2018, UNKNOWN_2004, Kanekiyo_2019 Mooney_2013, Mooney_2013
82 Wang_2013 DNA Immunization Wang, Shixia; Lu, Shan 2013 2013-11-05 PMC N PMC3920301 24510291.0 10.1002/9780471729259.mc1803s31 g8yzmtkj 0.343644 Forde_2005, Liu_S_2016, Li_L_2015 Liu_S_2016
83 Bowick_2010 Comparative Pathogenesis and Systems Biology for Biodefense Virus Vaccine Development Bowick, Gavin C.; Barrett, Alan D. T. 2010 2010-06-06 PMC N PMC2896660 20617142.0 10.1155/2010/236528 hmrr8zy7 0.342275 UNKNOWN_2004, Johnson_2018, Conzelmann_1996
84 Forde_2005 Rapid-response vaccines—does DNA offer a solution? Forde, Gareth M 2005 2005-01-01 PMC N PMC7097425 16151391.0 10.1038/nbt0905-1059 cdzgfsik 0.339998 Walker_2010
85 Ciafarone_2017 Vaccines, Sera and “New” Viruses: Ebola, Zika and Other Infectious Challenges for Human Health Ciafarone, Alessia; D’Amico, Argilia; Bologna, Mauro 2017 2017-07-06 PMC N PMC7123535 10.1007/978-94-024-1113-3_2 us984i0u 0.335325 Forde_2005
86 Rodrigues_2017 Whither vaccines? Rodrigues, Charlene M.C.; Pinto, Marta V.; Sadarangani, Manish; Plotkin, Stanley A. 2017 2017-06-30 PMC N 28646957.0 10.1016/s0163-4453(17)30184-6 w5nhgc1e 0.330271
87 Liu_S_2016 DNA immunization as a technology platform for monoclonal antibody induction Liu, Shuying; Wang, Shixia; Lu, Shan 2016 2016-04-06 COMM-USE N PMC4855071 27048742.0 10.1038/emi.2016.27 jnsis3gf 0.327742 Forde_2005
88 Murtaugh_2014 Advances in Swine Immunology Help Move Vaccine Technology Forward Murtaugh, Michael P. 2014 2014-06-01 PMC N PMC4107305 24630952.0 10.1016/j.vetimm.2014.02.017 bcv0cfm6 0.327176
89 Rodríguez-Limas_2013 Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development Rodríguez-Limas, William A; Sekar, Karthik; Tyo, Keith EJ 2013 2013-12-31 PMC N PMC7127385 23481378.0 10.1016/j.copbio.2013.02.008 co72yq2s 0.321084 Conzelmann_1996, Johnson_2018, Weinrich_2009 Syomin_2019
90 Pravieux_2007 Protection of Newborn Animals through Maternal Immunization Pravieux, J.J.; Poulet, H.; Charreyre, C.; Juillard, V. 2007 2007-07-31 PMC N PMC7094439 17559866.0 10.1016/j.jcpa.2007.04.009 3kod0oah 0.315965
91 Wen_Y_2016 Immunoregulatory functions of immune complexes in vaccine and therapy Wen, Yu‐mei; Mu, Libing; Shi, Yan 2016 2016-08-29 COMM-USE N PMC5048363 27572622.0 10.15252/emmm.201606593 tlfzjmju 0.311817 UNKNOWN_2004
92 Jones_2020 Innovations in HIV-1 Vaccine Design Jones, Letitia D.; Moody, M. Anthony; Thompson, Amelia B. 2020 2020-02-05 PMC N 10.1016/j.clinthera.2020.01.009 6yxe820s 0.302026 UNKNOWN_2020
93 Sullivan_2009 Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule Sullivan, Nancy J.; Martin, Julie E.; Graham, Barney S.; Nabel, Gary J. 2009 2009-01-01 PMC N PMC7097244 19369954.0 10.1038/nrmicro2129 gug45wqz 0.300207
94 Descotes_2012 Safety immunopharmacology: Evaluation of the adverse potential of pharmaceuticals on the immune system Descotes, Jacques 2012 2012-10-31 PMC N PMC7111030 22587937.0 10.1016/j.vascn.2012.05.001 5bbenze9 0.300183 Masihi_2005